REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 2 filers reported holding REPARE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,000 | -22.7% | 1,400 | -33.1% | 0.00% | – |
Q2 2023 | $22,000 | +266.7% | 2,093 | +230.6% | 0.00% | – |
Q1 2023 | $6,000 | -40.0% | 633 | -7.2% | 0.00% | – |
Q4 2022 | $10,000 | +25.0% | 682 | +9.1% | 0.00% | – |
Q3 2022 | $8,000 | -11.1% | 625 | 0.0% | 0.00% | – |
Q2 2022 | $9,000 | 0.0% | 625 | 0.0% | 0.00% | – |
Q1 2022 | $9,000 | -55.0% | 625 | -30.8% | 0.00% | – |
Q4 2021 | $20,000 | -42.9% | 903 | -32.0% | 0.00% | – |
Q3 2021 | $35,000 | -12.5% | 1,328 | +4.7% | 0.00% | – |
Q2 2021 | $40,000 | -2.4% | 1,268 | -6.5% | 0.00% | – |
Q1 2021 | $41,000 | +64.0% | 1,356 | +86.0% | 0.00% | – |
Q4 2020 | $25,000 | +316.7% | 729 | +264.5% | 0.00% | – |
Q3 2020 | $6,000 | +100.0% | 200 | +100.0% | 0.00% | – |
Q2 2020 | $3,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,646,657 | $28,001,631 | 33.22% |
MPM ASSET MANAGEMENT LLC | 2,242,636 | $23,727,089 | 11.64% |
CHI Advisors LLC | 2,998,734 | $31,726,606 | 9.63% |
MPM BioImpact LLC | 1,639,849 | $17,349,602 | 3.49% |
BVF INC/IL | 8,291,988 | $87,729,233 | 2.44% |
Deep Track Capital, LP | 2,727,606 | $28,858,071 | 1.34% |
Redmile Group, LLC | 2,428,335 | $25,691,784 | 0.99% |
HighVista Strategies LLC | 165,173 | $1,747,530 | 0.80% |
Orbimed Advisors | 3,322,488 | $35,151,923 | 0.64% |
DIFESA CAPITAL MANAGEMENT, LP | 15,416 | $163,101 | 0.43% |